CRT 2026
Heart Failure
Nisha Gilotra, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure(s): No financial relationships to disclose
Daniele Massera, MD, MSc
Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States
Disclosure(s): Chiesi Inc: Consulting Fees (e.g., advisory boards) (Terminated, April 30, 2025); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Rocket Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Cynthia Bither, NP
NP, Advanced Heart Failure Program
MedStar Washington Hospital Center
Shady Side, Maryland, United States
Disclosure(s): No financial relationships to disclose
Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA
executive director, Krannert Cardiovascular Research Center
Indiana University
Indianapolis, Indiana, United States
Disclosure(s): No financial relationships to disclose
Nisha Gilotra, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure(s): No financial relationships to disclose
Mitchell Psotka, MD PhD
System Chief, Heart Failure and Transplant
Inova Schar Heart and Vascular
Falls Church, Virginia, United States
Disclosure(s): No financial relationships to disclose
Tadahisa Sugiura, MD, PhD
Assistant Professor
Montefiore Medical Center/ Albert Einstein College of Medicine
Disclosure(s): No financial relationships to disclose